Advances and New Frontiers in the Pathophysiology of Venous Neointimal Hyperplasia and Dialysis Access Stenosis

Advances in Chronic Kidney Disease

Volumn 16, Issue 5, 2009, Pages 329-338

  Lee, Timmy ^a,b,c   Roy Chaudhury, Prabir ^a,b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Cincinnati Dialysis Access Program   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arteriovenous fistula; Arteriovenous grafts; Neointimal hyperplasia; Novel therapies; Vascular stenosis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA SMOOTH MUSCLE ACTIN; CLOPIDOGREL; DIPYRIDAMOLE; ELASTASE; ENDOTHELIN; GELATINASE A; HEME OXYGENASE 1; N(G),N(G) DIMETHYLARGININE; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR; POLITEF; PRT 201; RAPAMYCIN; RECOMBINANT ENZYME; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN D;

ADVENTITIA; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ARTERIOVENOUS FISTULA; ARTERIOVENOUS GRAFT STENOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIALYSIS ACCESS STENOSIS; DNA POLYMORPHISM; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR MATRIX; GENE THERAPY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPLASIA; INTIMA; KIDNEY FAILURE; KIDNEY GRAFT; MACROPHAGE; NEOVASCULARIZATION (PATHOLOGY); OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; POLITEF IMPLANT; PRIORITY JOURNAL; STENOSIS; TUNICA MEDIA; UREMIA; VASCULAR ACCESS; VASCULAR PATENCY; VEIN ANASTOMOSIS; VEIN NEOINTIMAL HYPERPLASIA;

ARTERIOVENOUS SHUNT, SURGICAL; CONSTRICTION, PATHOLOGIC; HUMANS; HYPERPLASIA; OXIDATIVE STRESS; RENAL DIALYSIS; TUNICA INTIMA; VEINS;

EID: 68649110742     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2009.06.009     Document Type: Article

References (65)

1. Feldman H.I., Kobrin S., and Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 7 (1996) 523-535
2. Roy-Chaudhury P., Arend L., Zhang J., et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis 50 (2007) 782-790
3. Roy-Chaudhury P., Kelly B.S., Miller M.A., et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 59 (2001) 2325-2334
4. Wang Y., Krishnamoorthy M., Banerjee R., et al. Venous stenosis in a pig arteriovenous fistula model-Anatomy, mechanisms and cellular phenotypes. Nephrol Dial Transplant 23 (2008) 525-533
5. Asif A., Gadalean F.N., Merrill D., et al. Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study. Kidney Int 67 (2005) 1986-1992
6. Weiss M.F., Scivittaro V., and Anderson J.M. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 37 (2001) 970-980
7. Beathard G.A., Arnold P., Jackson J., et al. Aggressive treatment of early fistula failure. Kidney Int 64 (2003) 1487-1494
8. Turmel-Rodrigues L., Pengloan J., Baudin S., et al. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant 15 (2000) 2029-2036
9. Roy-Chaudhury P, Wang Y, Krishnamoorthy M, et al: Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant (e-pub, doi:10.1093/ndt/gfn708), 2009.
10. Roy-Chaudhury P., Sukhatme V.P., and Cheung A.K. Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. J Am Soc Nephrol 17 (2006) 1112-1127
11. Lin T., Horsfield C., and Robson M.G. Arteriovenous fistula in the rat tail: A new model of hemodialysis access dysfunction. Kidney Int 74 (2008) 528-531
12. Chi-Jen C., Po-Jen K., Lung-An H., et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: Implication in prevention of restenosis. Am J Kidney Dis 43 (2004) 74-84
13. Roy-Chaudhury P., Asif A., Spergel L., and Besarab A. Biology of early AV fistula failure. J Nephrol 20 (2007) 150-163
14. Lehoux S. Redox signalling in vascular responses to shear and stretch. Cardiovasc Res 71 (2006) 269-279
15. Dixon B.S. Why don't fistulas mature?. Kidney Int 70 (2006) 1413-1422
16. Rotmans J.I., Velema E., Verhagen H.J., et al. Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model. J Vasc Surg 39 (2004) 432-439
17. Castier Y., Brandes R.P., Leseche G., et al. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 97 (2005) 533-540
18. Tronc F., Mallat Z., Lehoux S., et al. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: Interaction with NO. Arterioscler Thromb Vasc Biol 20 (2000) E120-E126
19. Misra S., Doherty M.G., Woodrum D., et al. Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 68 (2005) 2890-2900
20. Misra S., Fu A.A., Puggioni A., et al. Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am J Physiol Heart Circ Physiol 294 (2008) H2219-H2230
21. Misra S., Fu A.A., Rajan D.K., et al. Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and -9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas. J Vasc Interv Radiol 19 (2008) 252-259
22. Nath K.A. Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 70 (2006) 432-443
23. Juncos J.P., Tracz M.J., Croatt A.J., et al. Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int 74 (2008) 47-51
24. Lin C.C., Yang W.C., Lin S.J., et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 69 (2006) 165-172
25. Himmelfarb J., Stenvinkel P., Ikizler T.A., et al. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62 (2002) 1524-1538
26. Tepel M., van der Giet M., Statz M., et al. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: A randomized, controlled trial. Circulation 107 (2003) 992-995
27. Sezer S., Ozdemir F.N., Arat Z., et al. Triad of malnutrition, inflammation, and atherosclerosis in hemodialysis patients. Nephron 91 (2002) 456-462
28. Kokubo T., Ishikawa N., Uchida H., et al. CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol 20 (2009) 1236-1245
29. Liu B.C., Li L., Gao M., et al. Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis. Chin Med J (Engl) 121 (2008) 2157-2161
30. Stracke S., Konner K., Kostlin I., et al. Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int 61 (2002) 1011-1019
31. Mattana J., Effiong C., Kapasi A., et al. Leukocyte-polytetrafluoroethylene interaction enhances proliferation of vascular smooth muscle cells via tumor necrosis factor-alpha secretion. Kidney Int 52 (1997) 1478-1485
32. Kelly B.S., Heffelfinger S.C., Whiting J.F., et al. Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int 62 (2002) 2272-2280
33. Bolton C.H., Downs L.G., Victory J.G., et al. Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16 (2001) 1189-1197
34. Ghiadoni L., Cupisti A., Huang Y., et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol 17 (2004) 512-519
35. Wali M.A., Eid R.A., Dewan M., et al. Pre-existing histopathological changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction. Ann Thorac Cardiovasc Surg 12 (2006) 341-348
36. Feinfeld D.A., Batista R., Mir R., et al. Changes in venous histology in chronic hemodialysis patients. Am J Kidney Dis 34 (1999) 702-705
37. Ku Y.M., Kim Y.O., Kim J.I., et al. Ultrasonographic measurement of intima-media thickness of radial artery in pre-dialysis uraemic patients: Comparison with histological examination. Nephrol Dial Transplant 21 (2006) 715-720
38. Kim Y.O., Choi Y.J., Kim J.I., et al. The impact of intima-media thickness of radial artery on early failure of radiocephalic arteriovenous fistula in hemodialysis patients. J Korean Med Sci 21 (2006) 284-289
39. Zoccali C. Endothelial damage, asymmetric dimethylarginine and cardiovascular risk in end-stage renal disease. Blood Purif 20 (2002) 469-472
40. Kielstein J.T., and Zoccali C. Asymmetric dimethylarginine: A novel marker of risk and a potential target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 17 (2008) 609-615
41. Cooke J.P. Does ADMA cause endothelial dysfunction?. Arterioscler Thromb Vasc Biol 20 (2000) 2032-2037
42. Wu C.C., Wen S.C., Yang C.W., et al. Plasma ADMA predicts restenosis of arteriovenous fistula. J Am Soc Nephrol 20 (2009) 213-222
43. Scott N.A., Cipolla G.D., Ross C.E., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
44. Shi Y., O'Brien J.E., Fard A., et al. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94 (1996) 1655-1664
45. Shi Y., O'Brien Jr. J.E., Mannion J.D., et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 95 (1997) 2684-2693
46. Li L., Terry C.M., Blumenthal D.K., et al. Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant 22 (2007) 3139-3146
47. Roy-Chaudhury P., McKee L., et al. Adventitial fibroblasts contribute to venous neointimal hyperplasia in PTFE grafts]. J Am Soc Nephrol 12 (2001) 301A abstr
48. Caplice N.M., Wang S., Tracz M., et al. Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat. Am J Physiol Renal Physiol 293 (2007) F470-F475
49. Diao Y., Guthrie S., Xia S.L., et al. Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. Am J Pathol 172 (2008) 839-848
50. Castier Y., Lehoux S., Hu Y., et al. Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model. Kidney Int 70 (2006) 315-320
51. Dember L.M., Beck G.J., Allon M., et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial. JAMA 299 (2008) 2164-2171
52. Dixon B.S., Beck G.J., Dember L.M., et al. Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention of Access Stenosis Trial. Clin Trials 2 (2005) 400-412
53. Dixon B.S., Beck G.J., Vazquez M.A., et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 360 (2009) 2191-2201
54. Creel C.J., Lovich M.A., and Edelman E.R. Arterial paclitaxel distribution and deposition. Circ Res 86 (2000) 879-884
55. Kelly B., Melhem M., Zhang J., et al. Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model. Nephrol Dial Transplant 21 (2006) 2425-2431
56. Kohler T.R., Toleikis P., Gravett D.M., et al. Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable vascular wrap pacliteaxel eluting mesh. J Vasc Surg 45 (2007) 1029-1038
57. Paulson WD, Kipiani K, Beridze N, et al: Safety and efficacy of locally eluted sirolimus for prolonging AV graft patency (PTFE graft plus Coll-R) first in man experience (abstract). J Am Soc Nephrol 19:252A, 2008.
58. Nugent H.M., Groothuis A., Seifert P., et al. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: A safety and efficacy study in the pig. J Vasc Res 39 (2002) 524-533
59. Nugent H.M., Sjin R.T., White D., et al. Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J Vasc Surg 46 (2007) 548-556
60. Lawson JH, Glickman M, Schuman E, et al: Safety of Vascugel Treatment After the Creation of Arteriovenous Poster presented at: Philadelphia, PA, American Society of Nephrology Renal Week, November 4-9, 2008.
61. Hiltunen M.O., Laitinen M., Turunen M.P., et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102 (2000) 2262-2268
62. Burke SK, LaRochelle A, Mendenhall HV: Local Application of Recombinant Human Type I Pancreatic Elastase (PRT-201) to an Arteriovenous Fistula (AVF) Increases AVF Blood Flow in a Rabbit Model Poster presented at: Philadelphia, PA, American Society of Nephrology Renal Week, November 4-9, 2008.
63. Roy-Chaudhury P., and for The Mercator Study Investigators Perivascular Dexamethasone for PTFE Graft Stenosis. The HAPPI (Hemodialysis Access Patency Extension with Percutaneous Transluminal Infusion of Dexamethasone) Study. J Am Soc Nephrol 18 (2007) 468A
64. Croatt A.J., Juncos J.P., Hernandez M.C., et al. Upregulation of inflammation-Related Genes and Neointima Formation in Arteriovenous Fistula (AVF) Model in the Rat (Abstract). J Am Soc Nephrol 19 (2008) 252A
65. Misra S., Fu A.A., Puggioni A., et al. Proteomic profiling in early venous stenosis formation in a porcine model of hemodialysis graft. J Vasc Interv Radiol 20 (2009) 241-251